In chemical carcinogenicity and drug-safety testing, a cacinogen is defined as an agent that when administered by an appropriate route causes an increased incidence of tumors in experimental animals as compared to unexposed control animals. Although a carcinogen may cause the appearance of tumors in organs where tumors do not usually occur in a given strain, the usual response is to increase the types of tumors seen spontaneously and to shorten the period of latency. The use of cacinogenesis experiments for research and safety assessment requires properly designed and well-conducted experiments and a knowledge of background data and variations in tumor incidences of control animals. Many factors can influence the reported incidences of spontaneous tumors. These include species, strain, sex, age, and source of the experimental test animal; study duration; extent of the pathology examination; dietary and environmental conditions; qualifications and experience of the study pathologist; diagnostic criteria and nomenclature conventions; and quality assurance and review procedures. This paper discusses several factors which may influence the incidence of tumors in control and test animals, and provides examples to illustrate the potential for these factors to affect the data.
References
1.
1. Altman NH and Goodman DG (1979). Neoplastic diseases. In: The Laboratory Rat, HJ Baker, JR Lindsey, and SH Weisbroth (eds). Academic Press, New York, Vol. 1, pp. 334–378.
2.
2. Anver MR, Cohen BJ, Lattuada CP, and Foster SJ (1982). Age-associated lesions in barrier-reared male Sprague-Dawley rats: a comparison between Hap:(SD) and Crl:COBS(R)CD(E) (SD) stocks. Exp. Aging Res.8: 3–24.
3.
3. Bickerton RK (1976). Section 11: Report of discussion group no. 7-Spontaneous tumors and related pathologic changes. In: Carcinogenesis Testing of Chemicals, Leon Golberg (ed). CRC Press, Boca Raton, FL, pp. 55–70.
4.
4. Boorman GA and DcLellis RA (1983). C-Cell hyperplasia, thyroid, rat; c-cell adenoma, thyroid, rat; medullary carcinoma, thyroid, rat. In: Endocrine System, TC Jones, U Mohr, and RD Hunt, (eds). pp. 192–204.
5.
5. Boorman GA, Montgomery CA, Hardisty JF, Eustis SL, Wolfe MJ, and McConnell EE, (1985). Quality assurance in pathology for rodent toxicology and carcinogenicity tests. In: Handbook of Carcinogenesis Testing, H. Milman and J. Weisberger (eds). Noyes Publications, Parkridge, NJ.
6.
6. Coleman GL, Barthold SW, Osbaldiston GW, Foster SJ, and Jonas AM (1977). Pathological changes during aging in barrier-reared Fischer 344 male rats. J. Gerontol.32: 258–278.
7.
7. Davis RK, Stevenson GT, and Busch KA (1956). Tumor incidence in normal Sprague-Dawley female rats. Cancer Res.16: 194–197.
8.
8. DeLellis RA, Nunnemacher G, Bitman WR, Gagel RF, Tashjian AH, Blount M, and Wolfe HJ (1979). C-cell hyperplasia and medullary thyroid carcinoma in the rat: an immunohistochemical and ultrastructural analysis. Lab. Invest.40: 140–154.
9.
9. Frith CH, Boothe AD, Greenman DL, and Farmer JH (1979). Correlations between gross and microscopic lesions in carcinogenic studies in mice. J. Environ. Pathol. Toxicol.3: 139–153.
10.
10. Goodman DG, Ward JM, Squire RA, Chu KC, and Linhart MS (1979). Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol.48: 237–248.
11.
11. Goodman DG, Ward JM, Squire RA, Paxton MB, Reichardt WD, Chu KC and Linhart MS (1980). Neoplastic and nonneoplastic lesions in aging Os-borne-Mendel rats. Toxicol. Appl. Pharmacol.55: 433–447.
12.
12. Haseman JK (1983). Patterns of tumor incidence in two-year cancer bioassay feeding studies in Fischer 344 rats. Fundam. Appl. Toxicol.3: 1–9.
13.
13. Haseman JK, Huff JA, and Boorman GA (1985). Use of historical control data in carcinogenicity studies. Toxicol. Pathol, (in press).
14.
14. Huff JE and Moore JA (1984). Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program.Industrial Hazards of Plastics and Synthetic Elastomers43–64.
15.
15. Jacobs BB and Huseby RA (1967). Neoplasms occurring in aged Fischer rats, with special reference to testicular, uterine, and thyroid tumors. J. Natl. Cancer. Inst.39: 303–309.
16.
16. Kulwich BA, Hardisty JF, Gilmore CE, and Ward JM (1980). Correlations between gross observations of tumors and neoplasms diagnosed microscopically in carcinogenesis bioassays in rats. J. Environ. Pathol. Toxicol.3: 281–287.
17.
17. MacKenzie WF, and Garner FM (1973). Comparison of neoplasms in six sources of rats. J. Nail. Cancer Inst.50: 1243–1257.
18.
18. Madison RM, Rabstein LS, and Bryan WR (1968). Mortality rate and spontaneous lesions found in 2,928 untreated BALB/cCr mice. J. Nail. Cancer Inst.40: 683–685.
19.
19. Maekawa A, Kurokawa Y, Takahashi M, Kokubo T, Ogiu T, Onodera H, Tanigawa H, Ohno Y, Furukawa F, and Hayashi Y (1983). Spontaneous tumors in F-344/DuCrj rats.Gann74: 365–372.
20.
20. Newberne PM and McConnell RG (1980). Toxicologic pathology: issues and uncertainties. In: The Principles and Methods in Modern Toxicology, CL Galli, SD Murphy, and R Paoletti (eds). Elsevier, Amsterdam, pp. 223–258.
21.
21. Prejean JD, Peckham JC, Casey AE, Griswold DP, Weisburger EK. and Weisburger JH (1973). Spontaneous tumors in Sprague-Dawley rats and Swiss mice. Cancer Res.33: 2768–2773.
22.
22. Sacksteder MR (1976). Brief communication: Occurrence of spontaneous tumors in the germ-free F344 rat. Natl. Cancer Inst.57: 1371–1373.
23.
23. Sass B, Rabstein RS, Madison R, Nims RM, Peters RL, and Kelloff GJ (1975). Incidence of spontaneous neoplasms in F344 rats throughout the natural lifespan. J Natl. Cancer Inst.54: 1449–1456.
24.
24. Schardein JL, Fitzgerald JE, and Kaump DH (1968). Spontaneous tumors in Holtzman-source rats of various ages. Pathol. Vet.5: 238–252.
25.
25. Sheldon WG and Greenman DL (1979). Spontaneous lesions in control BALB/c female mice. J. Environ. Pathol. Toxicol.3: 155–167.
26.
26. Sher SP, Jensen RD, and Bokelman DL (1982). Spontaneous tumors in control F344 and Charles River-CD rats and Charles River CD-1 and B6C3F1 mice. Toxicol. Lett.11: 103–110.
27.
27. Solleveld HA, Haseman JK, and McConnell EE (1984). The natural history of body weight gain, survival and neoplasia in the Fischer 344 rat. J. Natl. Cancer Inst.
28.
28. Sontag JM. Page NP, and Saffiotti U (1976). Guidelines for carcinogen bioassay in small rodents. NCI Carcinogenesis Tech. Hep. Ser. 1.
29.
29. Squire RA, Goodman DG, Valerio MG, Fredrickson TN, Strandburg JD, Levitt MH, Lingeman CH, Harshbarger JC, and Dawe CJ (1978). Tumors. In: Pathology of Laboratory Animals, K Benirschke, FM Garner, and TC Jones (eds). Springer-Verlag, New York, Vol. II, pp. 1057–1284.
30.
30. Takizawa S, and Miyamoto M (1976). Observations on spontaneous tumors in Wistar Furth strain rats. Hiroshima J. Med. Sci.25: 59–98.
31.
31. Tarone RE, Chu KC, and Ward JM (1981). Variability in the rates of some common naturally occurring tumors in Fischer 344 rats and (C57B1/6N X C3H/HeN)F1 (B6C3F1) mice. Natl. Cancer Inst.66: 1175–1181.
32.
32. Thompson SW, and Hunt RD (1963). Spontaneous tumors in the Sprague-Dawley rat: incidence rates of some types of neoplasms as determined by serial section versus single section technics.Ann. N. Y. Acad. Sci.108: 832–845.
33.
33. Thompson SW, Huseby RA, Fox MA, Davis CL, and Hunt RD (1961). Spontaneous tumors in the Sprague-Dawley rat.J. Nail. Cancer Inst.27: 1037–1057.
34.
34. Ward JM (1983). Background data and variations in tumor rates of control rats and mice. Prog. Exp. Tumor Res.26: 241–258.
35.
35. Ward JM, Goodman DG, Griesemer RA, Hardisty JF, Schueler RL, Squire RA, and Strandberg JD (1978). Quality assurance of pathology in rodent carcinogenesis tests. J. Environ. Pathol. Toxicol.2: 371–378.
36.
36. Ward JM, Goodman DG, Squire RA, Chu KC, and Linhart MS (1979). Neoplastic and nonneoplastic lesions in aging (C57B1/6N X C3H/HeN)F1 (B6C3F1) mice. J. Natl. Cancer Inst.63: 849–854.
